Serum Inflammatory Markers for Periprosthetic Knee Infection in Obese Versus Non-Obese Patients

被引:22
|
作者
Liu, Jane Z. [1 ,2 ]
Saleh, Anas [1 ]
Klika, Alison K. [1 ]
Barsoum, Wael K. [1 ]
Higuera, Carlos A. [1 ]
机构
[1] Cleveland Clin Fdn, Dept Orthopaed Surg, Orthopaed & Rheumatol Inst, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
来源
JOURNAL OF ARTHROPLASTY | 2014年 / 29卷 / 10期
关键词
total knee arthroplasty; periprosthetic infection; obesity; C-reactive protein; diagnosis; C-REACTIVE PROTEIN; JOINT INFECTION; UNITED-STATES; TOTAL HIP; ARTHROPLASTY; OSTEOARTHRITIS; TISSUE; OA;
D O I
10.1016/j.arth.2014.07.005
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Accurate diagnosis of periprosthetic joint infection (PJI) is challenging. Most infection diagnosis criteria define elevated serum C-reactive protein (CRP) as >1.0 mg/dL and erythrocyte sedimentation rate (ESR) as >30 mm/hour. Obesity has been reported as a pro- inflammatory state with elevated baseline CRP values. We hypothesized that higher cut-off values would be more accurate to diagnose PJI in obese patients due to their elevated baseline CRP. BMI, serum inflammatory markers, and synovial fluid were collected for 102 revision total knee arthroplasty patients, and analyzed for the highest area under the curve. We found a CRP of 3.6 mg/dL was more accurate to diagnose PJI in obese patients versus traditional values. Clinicians should be judicious and use additional criteria when diagnosing PJI in obese patients. (c) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1880 / 1883
页数:4
相关论文
共 50 条
  • [1] Outcome following total knee arthroplasty in obese versus non-obese Asian patients
    Goh, Graham Seow-Hng
    Liow, Ming Han Lincoln
    Mitra, Amit Kanta
    JOURNAL OF ORTHOPAEDIC SURGERY, 2015, 23 (03) : 294 - 297
  • [2] Metabolic Profile And Inflammatory Markers In Obese And Non-obese Elder Adults
    Xue, Jingjing
    Li, Shuo
    Hu, Yanru
    Hong, Ping
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 1040 - 1040
  • [3] KNEE ARTHROSCOPIC VISIBILITY ALTERATIONS IN OBESE AND NON-OBESE PATIENTS
    Zini, Cassio
    Stieven-Filho, Edmar
    Tabushi, Fernando Issamu
    Paredes Marcondes Ribas, Carmen Australia
    Ribas, Fernanda Marcondes
    Opolski, Ana Cristina
    Erbano, Bruna Olandoski
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2016, 29 : 75 - 79
  • [4] Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
    Agacayak, Elif
    Tunc, Senem Yaman
    Sak, Sibel
    Basaranoglu, Serdar
    Yuksel, Hatice
    Turgut, Abdulkadir
    Gul, Talip
    MEDICAL SCIENCE MONITOR, 2015, 21 : 2446 - 2455
  • [5] Glimepiride pharmacokinetics in obese versus non-obese diabetic patients
    Shukla, UA
    Chi, EM
    Lehr, KH
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) : 30 - 35
  • [6] ARGATROBAN DOSE REQUIREMENTS IN OBESE VERSUS NON-OBESE PATIENTS
    McCleary, Emily
    Ashton, Jennifer
    Zumberg, Marc
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [7] Endothelial wall thickness, cardiorespiratory fitness and inflammatory markers in obese and non-obese adolescents
    Silva, Larissa R.
    Cavaglieri, Claudia
    Lopes, Wendell A.
    Pizzi, Juliana
    Coelho-e-Silva, Manuel J. C.
    Leite, Neiva
    BRAZILIAN JOURNAL OF PHYSICAL THERAPY, 2014, 18 (01) : 47 - 55
  • [8] Outcomes of inflammatory bowel disease surgery in obese versus non-obese patients: a meta-analysis
    G. Hicks
    A. Abdulaal
    A. A. P. Slesser
    Y. Mohsen
    Techniques in Coloproctology, 2019, 23 : 947 - 955
  • [9] Outcomes of inflammatory bowel disease surgery in obese versus non-obese patients: a meta-analysis
    Hicks, G.
    Abdulaal, A.
    Slesser, A. A. P.
    Mohsen, Y.
    TECHNIQUES IN COLOPROCTOLOGY, 2019, 23 (10) : 947 - 955
  • [10] ASSESSMENT OF IMMUNE PARAMETERS IN OBESE VERSUS NON-OBESE ASTHMA PATIENTS
    Yeryomenko, G.
    Bezditko, T.
    DuBuske, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S45 - S45